Merits and challenges of iPSC-derived organoids for clinical applications.

Ziran Xu, Jiaxu Yang, Xianyi Xin, Chengrun Liu, Lisha Li, Xianglin Mei, Meiying Li

May 2023 Front Cell Dev Biol

Synopsis of Social media discussions

The overall tone of the discussions reflects excitement and acknowledgment of the importance of iPSC-derived organoids, with comments analyzing their potential in disease modeling and therapy. Words like 'unprecedented,' 'critical,' and 'revolutionize' suggest optimism, while mentioning challenges indicates an understanding of current limitations, demonstrating moderate engagement and high interest in future developments.

A
Agreement
 Moderate agreement

Most discussions acknowledge the significance of iPSC-derived organoids in medical research, reflecting a general consensus on their potential.

I
Interest
 High level of interest

The conversations highlight strong curiosity about advancements and applications, indicating high interest from participants.

E
Engagement
 Moderate level of engagement

Many posts delve into specific challenges and future implications, showing moderate to deep involvement with the topic.

I
Impact
 Moderate level of impact

Participants seem to recognize that overcoming current hurdles could greatly influence regenerative medicine and disease modeling, hence a positive impact perception.

Social Mentions

YouTube

1 Videos

Twitter

1 Posts

Metrics

Video Views

29

Total Likes

1

Extended Reach

3,832

Social Features

2

Timeline: Posts about article

Top Social Media Posts

Posts referencing the article

Advances and Challenges in iPSC-Derived Organoids for Medicine

Advances and Challenges in iPSC-Derived Organoids for Medicine

Induced pluripotent stem cells have advanced significantly and are crucial for disease modeling, drug development, and regenerative medicine, especially through 3D organoid systems that mimic true organ structure and function. Despite their potential, challenges remain.

Social RTCL TV

August 20, 2023

29 views

  • Frontiers - Cell Biology
    @FrontCellDevBio (Twitter)

    New Research: Merits and challenges of iPSC-derived organoids for clinical applications: Induced pluripotent stem cells (iPSCs) have entered an unprecedented state of development since they were first generated. They have played a critical… #celldevbio https://t.co/BeuRhVYbKe
    view full post

    May 26, 2023

Abstract Synopsis

  • Induced pluripotent stem cells (iPSCs) have advanced significantly and are now crucial for disease modeling, drug development, and regenerative medicine, especially when combined with 3D organoid culture systems that mimic true organ structure and function.
  • Organoids derived from iPSCs can model organ development, regeneration, and disease processes, providing insights into biological regulation and pathological mechanisms, including applications in COVID-19 treatment.
  • Despite their potential, there are still unresolved challenges and limitations in using iPSC-derived organoids for clinical applications, which need addressing to fully realize their therapeutic benefits.]